Development of gemifloxacin in vitro susceptibility test methods for gonococci including quality control guidelines
- 31 July 2000
- journal article
- guideline
- Published by Elsevier in Diagnostic Microbiology and Infectious Disease
- Vol. 37 (3) , 195-201
- https://doi.org/10.1016/s0732-8893(00)00139-5
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Antimicrobial activity of gatifloxacin tested against Neisseria gonorrhoeae using three methods and a collection of fluoroquinolone-resistant strainsDiagnostic Microbiology and Infectious Disease, 1998
- Intercity spread of gonococci with decreased susceptibility to fluoroquinolones: a unique focus in the United States.The Journal of Infectious Diseases, 1998
- Antimicrobial resistance in gonococci isolated from patients and from commercial sex workers in Harare, ZimbabweInternational Journal of Antimicrobial Agents, 1998
- Antimicrobial activity of trovafloxacin tested against ciprofloxacin-susceptible and -resistant Neisseria gonorrhoeae interpretive criteria and comparisons with Etest resultsDiagnostic Microbiology and Infectious Disease, 1997
- Antimicrobial Resistance inNeisseria gonorrhoeaein the United States, 1988–1994: The Emergence of Decreased Susceptibility to the FluoroquinolonesThe Journal of Infectious Diseases, 1997
- High-Level Quinolone Resistance in Neisseria gonorrhoeae; A Report of Two CasesSexually Transmitted Diseases, 1995
- Structure-activity and structure-side-effect relationships for the quinolone antibacterialsJournal of Antimicrobial Chemotherapy, 1994
- Interpretive criteria, quality control guidelines, and drug stability studies for susceptibility testing of cefotaxime, cefoxitin, ceftazidime, and cefuroxime against Neisseria gonorrhoeaeDiagnostic Microbiology and Infectious Disease, 1990
- Decreased susceptibility of Neisseria gonorrhoeae to ciprofloxacinThe Lancet, 1990